← Medical · Causes of death · how systems treat it
Injury / external · Master rank #36 · ~0.7% of deaths (Top 20 avg)
Short comparison of all 20 systems on one page. Click a country for the full treatment / prevention / lifestyle page.
High-tech acute care; prior auth; huge price variation by payer. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Fentanyl-driven overdose crisis; naloxone + uneven MOUD access
Single-payer core with wait times; limited private parallel. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Provincial toxic-drug emergencies; safer-supply pilots vary
Strong primary care gatekeeping with private hospital overflow. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via Universal Medicare + private optional.
GP gatekeeping, NICE pathways, waiting-list rationing for elective care. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. NICE-guided MOUD; regional variation in harm reduction
Pharmac constrains drug spend; public hospitals for major care. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via Tax-funded + private optional.
Ambulatory specialist access; strong pharma/device availability. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via Statutory health insurance.
High ambulatory volume; global budgets constrain growth. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via NHI single payer.
Municipal prevention + regional hospitals. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via Tax-funded.
Strong primary care; Mediterranean public-health framing. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via SNS tax-funded.
Ambulatory specialists + hospital sector; dense capacity. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via Statutory sickness funds.
Fund-integrated care; strong tech/trauma capacity. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via Mandatory health funds.
GP gatekeeping; north/south performance gaps. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via SSN tax-funded.
Primary-care centered; strong public health infrastructure. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via Decentralized tax-funded.
Wealthy Nordic model; GP lists + municipal prevention. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via Tax-funded national system.
Insurer-organized pathways; low uninsured rate. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via Mandatory private insurance, regulated.
High spend, high access, canton variation. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via Mandatory private insurance.
Public primary care + occupational health overlay. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via Tax-funded / reforming.
High visit frequency, low unit prices, specialist access without US-style referral walls. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via Statutory insurance, fee schedule.
Public clusters for most serious care; private ISP for those who pay up. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via S+3Ms (subsidy + MediSave + MediShield + MediFund).
Very high utilization; hospital-heavy; aggressive screening culture. US is the extreme on fentanyl/overdose; others emphasize harm reduction differently. Injury / external pathway via NHI single payer + private hospitals.